CASTLE BIOSCIENCES INC financial data

Symbol
CSTL on Nasdaq
Location
Friendswood, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 734% % -4.6%
Quick Ratio 17% % -10%
Debt-to-equity 18% % 15%
Return On Equity -3% % -284%
Return On Assets -2% % -280%
Operating Margin -10% % -2957%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29,188,659 shares 4.2%
Common Stock, Shares, Outstanding 29,161,863 shares 4.2%
Entity Public Float $587,000,000 USD 89%
Weighted Average Number of Shares Outstanding, Basic 29,073,000 shares 4.4%
Weighted Average Number of Shares Outstanding, Diluted 29,073,000 shares -1.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $343,530,000 USD 10%
Cost of Revenue $68,896,000 USD 22%
Research and Development Expense $50,108,000 USD -5.9%
Operating Income (Loss) $34,933,000 USD -3265%
Income Tax Expense (Benefit) $6,679,000 USD -232%
Net Income (Loss) Attributable to Parent $12,236,000 USD -301%
Earnings Per Share, Basic 0 USD/shares -278%
Earnings Per Share, Diluted 0 USD/shares -305%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $85,556,000 USD -9.9%
Marketable Securities, Current $201,986,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $49,482,000 USD -1.6%
Inventory, Net $8,650,000 USD 32%
Assets, Current $357,569,000 USD 3.7%
Operating Lease, Right-of-Use Asset $15,151,000 USD 27%
Goodwill $10,700,000 USD 0%
Other Assets, Noncurrent $1,282,000 USD -30%
Assets $562,786,000 USD 9.4%
Accounts Payable, Current $12,211,000 USD 79%
Employee-related Liabilities, Current $31,763,000 USD 15%
Liabilities, Current $55,308,000 USD 25%
Deferred Income Tax Liabilities, Net $3,242,000 USD -23%
Operating Lease, Liability, Noncurrent $25,302,000 USD 72%
Other Liabilities, Noncurrent $16,000 USD -71%
Liabilities $95,740,000 USD 30%
Accumulated Other Comprehensive Income (Loss), Net of Tax $240,000 USD -49%
Retained Earnings (Accumulated Deficit) $221,952,000 USD -5.8%
Stockholders' Equity Attributable to Parent $467,046,000 USD 5.9%
Liabilities and Equity $562,786,000 USD 9.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $6,036,000 USD 12%
Net Cash Provided by (Used in) Financing Activities $1,553,000 USD -115%
Net Cash Provided by (Used in) Investing Activities $22,431,000 USD -14%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 29,161,863 shares 4.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $30,020,000 USD -89%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85,556,000 USD -9.9%
Deferred Tax Assets, Valuation Allowance $50,536,000 USD -8.2%
Deferred Tax Assets, Gross $73,217,000 USD -7.9%
Operating Lease, Liability $16,010,000 USD 4.6%
Depreciation $5,860,000 USD 33%
Payments to Acquire Property, Plant, and Equipment $4,740,000 USD -48%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,469,000 USD -288%
Lessee, Operating Lease, Liability, to be Paid $22,757,000 USD -6.4%
Operating Lease, Liability, Current $1,449,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,399,000 USD 6.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,948,000 USD 27%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $770,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,747,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,443,000 USD 9.3%
Deferred Tax Assets, Operating Loss Carryforwards $31,782,000 USD -33%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,494,000 USD 1.5%
Additional Paid in Capital $688,729,000 USD 5.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $36,902,000 USD 308%
Depreciation, Depletion and Amortization $29,764,000 USD 791%
Deferred Tax Assets, Net of Valuation Allowance $22,681,000 USD -7.3%
Share-based Payment Arrangement, Expense $45,926,000 USD -9.4%
Interest Expense $9,000 USD -96%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%